Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Pathogens (Basel, Switzerland)|July 30, 2025
Expanding the Antiviral Spectrum of Scorpion-Derived Peptides Against Toscana Virus and Schmallenberg VirusRosa Giugliano, Carla Zannella, Roberta Della Marca, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|March 12, 2024
Oreoch-1: A broad-spectrum virus and host-targeting peptide against animal infectionsBianca M Nastri, Annalisa Chianese, Rosa Giugliano, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Structural and Mechanistic Basis for Antibody Neutralization of the Measles Fusion ProteinDawid S Zyla, Roberta Della Marca, Davide Lacarbonara, et al.
The Journal of Headache and Pain|March 23, 2023
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 studyPiero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Stroke Research and Treatment|November 8, 2018
Longitudinal Study on Low-Dose Aspirin versus Placebo Administration in Silent Brain Infarcts: The Silence StudyIlaria Maestrini, Marta Altieri, Laura Di Clemente, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Stabilized Full-Length Measles Fusion Protein Elicits Potent Immunity and Protection In VivoDawid S Zyla, Gillian Zipursky, Roberta Della Marca, et al.
Journal of Neurology|January 17, 2024
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational studyPiero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Neurology and Therapy|March 7, 2024
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 StudyPiero Barbanti, Gabriella Egeo, Stefania Proietti, et al.
Nature Communications|April 6, 2026
Structural and mechanistic basis for antibody neutralization of the measles fusion proteinDawid S Zyla, Roberta Della Marca, Davide Lacarbonara, et al.
The Journal of Headache and Pain|October 2, 2025
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE)Piero Barbanti, Giulia Fiorentini, Cecilia Camarda, et al.
Pageof 2